Jubilant Biosys Limited

A celebration of culture, connection and the people behind our science. As India marked its 80th Independence Day, colleagues across Jubilant Biosys came together to honour the spirit of freedom, unity and responsibility. From flag-hoisting ceremonies to vibrant traditional celebrations, every moment reflected the pride we share in our nation and in one another. Here are a few glimpses from the celebrations. #IndependenceDay #LifeAtJubilantBiosys

On India’s 80th Independence Day, we celebrate the researchers building a healthier, freer future through science and innovation. #80thIndependenceDay #JubilantBiosys #CRDMO

A Breath of Fresh Air for a Sustainable Future! A new green space was inaugurated at our CDMO and API manufacturing facility in Nanjangud by Mr. Shantanu Jha (Acting CEO, Jubilant Biosys & Group CHRO). As part of our ongoing sustainability efforts, the garden includes a selection of plants recognized by NASA for their air-purifying qualities, helping create a greener and more pleasant workplace. The initiative reinforces our ESG commitments and reflects our belief of fostering a healthier and greener environment through simple yet meaningful actions.

Drug discovery success depends on more than scientific expertise. It requires the right infrastructure, integrated capabilities, and the ability to scale seamlessly. At Jubilant Biosys, we bring together discovery, development, and manufacturing within a connected CRDMO ecosystem, helping advance programs from early discovery toward IND readiness. ✔ 100+ IDD programs delivered ✔ 400+ clones generated ✔ 300 proteins delivered across ~80 targets ✔ 445+ co-crystal structures across ~40 targets ✔ 2M+ compound knowledge base Partner with a team built for scale, speed, and scientific excellence. #JubilantBiosys #IntegratedDrugDiscovery #CRDMO #DrugDiscovery #Biotech #PharmaInnovation #IDD

We’re heading to ACS Fall 2026 in Chicago! Meet the Jubilant Biosys team at Booth #639 to discuss how our chemistry expertise can support your drug discovery programs - from compound design and synthesis to medicinal chemistry and lead optimization. Whether you’re exploring a new target, progressing a chemical series, or looking for an experienced CRDMO partner, we look forward to learning more about your research and discussing how we can work together. 📅 August 23–27, 2026 📍 Chicago, Illinois 📌 Booth #639 American Chemical Society #ACSFall2026 #CRDMO #DrugDiscovery #Pharma #LifeSciences

We are #Hiring! Jubilant Biosys is a large and diverse organization where many talented people have built successful careers. As a leading contract research organization in India, we offer an innovative and collaborative environment where motivated people can showcase their talent. We are thrilled to announce exciting opportunities for talented individuals to join us as Research Associates/Senior Research Associates in Synthesis and PR&D & Scale-Up department. As part of our team, you'll be responsible for a diverse range of tasks within the drug discovery process. In this role, you will have ample opportunities to collaborate with our dynamic team, providing scientific expertise and strategic leadership. If you're passionate about making a difference in drug discovery and are ready to contribute your skills, Jubilant is the right place for you! Apply now and embark on an enriching journey with Jubilant Biosys Limited. Let's shape the future of healthcare together! Pritesh Bhatia | Vinay Sharma | Seema Bhatt | Aditi Yadav #CRO #CDMO #CRDMO #hiring #vacancy #synthesis #chemistry #science #Jubilantbiosys

Need additional medicinal or synthetic chemistry capacity without increasing headcount? Jubilant Biosys provides dedicated FTE teams tailored to your program, with seamless access to CADD, biology, and DMPK expertise. ✔ 30-50 compounds per DMTA cycle ✔ 1-2 week turnaround times ✔ Flexible team scaling based on project needs Discover how our integrated model can help accelerate your pipeline. #CRO #CDMO #CRDMO #Chemistry #FTE #DMPK #Biology #science #innovation #CADD

Great process development begins with a vision that extends beyond the laboratory. The true measure of success lies in creating processes that are safe, scalable, sustainable, and ready for commercial manufacturing. Bimalendu Roy, Director, Scale-up & Process Research & Development shares his perspective on the evolving role of process development in building future-ready manufacturing solutions. At Jubilant Biosys, we combine scientific innovation with practical manufacturing insights to develop robust and efficient processes that support seamless scale-up and long-term performance. By embedding sustainability, operational excellence, and quality-by-design principles into every stage of development, we help our partners accelerate their journey from concept to commercialization. #ProcessDevelopment #ScaleUp #ProcessInnovation #GreenChemistry #CRDMO #CDMO #Manufacturing #Excellence #JubilantBiosys

Seoul, Here We Come! Jubilant Biosys is all set for CPHI Korea 2026, one of Asia's premier pharmaceutical industry gatherings. Meet our business development team and discover how our integrated capabilities across Drug Discovery, Development, API, and CDMO services can support your pipeline from concept to commercialization. 📅 25-27 August 2026 📍 COEX, Seoul 🏢 Booth #EG08 Meet our team • Jinang Parekh, Vice President & Head-BD (API & CDMO) • Vandana Mamgain, Associate Director - Sales & BD We look forward to meaningful conversations, new partnerships, and opportunities to advance healthcare innovation together. #CPHIKorea2026 #LifeSciences #Pharmaceuticals #API #CDMO #DrugDiscovery #JubilantBiosys

AI is transforming molecular design by generating novel structures and accelerating hypothesis generation. Yet, the path from prediction to a viable drug candidate still depends on rigorous experimental science. Success requires the seamless integration of chemistry, biology, DMPK, analytical sciences, and development expertise to validate, optimize, and advance promising molecules. At Jubilant Biosys, our integrated CRDMO platform bridges the gap between AI-driven insights and real-world execution, helping innovators move from molecule design to development-ready candidates with confidence. #AI #DrugDiscovery #CRDMO #MedChem #DrugDevelopment #MachineLearning #Biology #DMPK #JubilantBiosys